Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal s
administrator
Related Articles
Help the FDA Prevent the Sale of Tobacco…
- October 23, 2025
Jody’s Inc. Recalls Cabot Creamery Sea Salt Caramel…
- October 17, 2025
Jody’s Inc. Recalls Cabot Creamery Sea Salt Caramel…
- October 17, 2025